OPXA: To Present At Rodman & Renshaw Investment Conference @ 17:45 ET [delayed] -
Opexa to Present at the Rodman & Renshaw 10th Annual Healthcare Conference -
Opexa reports additional positive data from Phase IIb multiple sclerosis study -
BRIEF-Opexa Therapeutics reports Q3 results -
OPEXA THERAPEUTICS INC REUTERS ESTIMATES Q3 SHR VIEW $-0.31 -
OPEXA THERAPEUTICS INC Q3 SHR LOSS $0.28 -
Opexa reports top-line data from Phase IIb multiple sclerosis study -
Opexa and MRF collaborate on multiple sclerosis research program -
OPXA: Research Partnership w/Myelin Repair Foundation -
Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program -
Opexa Therapeutics Reports Second Quarter 2008 Financial Results and Recent Corporate Highlights -
Opexa Therapeutics Inc concludes private placement -
Opexa Therapeutics Completes $3 Million Financing -
Opexa wins positive review for Phase IIb multiple sclerosis study -
OPXA: Data Safety Monitoring Board Recommends Continuation of Ph IIb Study -
Opexa's Phase IIb Study of Tovaxin(R) Receives Positive Review from Data Safety Monitoring Board -